The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis
Open Access
- 1 May 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 6 (3) , 423-426
- https://doi.org/10.1002/hep.1840060317
Abstract
Wedged hepatic venous pressure, free hepatic venous pressure and cardiac index were measured before and 1 hr after i.v. administration as well as 1 month and 3 months after chronic oral administration of verapamil in 10 patients with HBsAg-positive cirrhosis. The gradient between wedged hepatic venous pressure and free hepatic venous pressure was decreased 14% at 1 hr after i.v. administration of 10 mg verapamil, and the sustained decrease in hepatic venous pressure gradient was also demonstrated in the patients after 1 month, and in six patients after 3 months of continuous oral administration of verapamil. The mean arterial pressure significantly decreased (p<0.01) 1 hr after the administration of verapamil. There was no significant change in other hemodynamic values. We conclude that chronic oral administration of verapamil can reduce the hepatic venous pressure gradient in patients with compensated HBsAg-positive cirrhosis and portal hypertension.This publication has 16 references indexed in Scilit:
- A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final ReportHepatology, 1984
- Propranolol in Portal Hypertension: Problems in Paradise?Hepatology, 1984
- Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with CirrhosisNew England Journal of Medicine, 1983
- Precipitation of hepatic encephalopathy by propranolol in cirrhosis.BMJ, 1983
- The Detrimental Effects of Adrenocorticosteroid Therapy in Hbsag–Positive Chronic Active Hepatitis: Fact or Artifact?Hepatology, 1982
- PROPRANOLOL INCREASES ARTERIAL AMMONIA IN LIVER CIRRHOSISThe Lancet, 1982
- Comparison of the Effects of A Cardioselective and A Nonselective β–Blocker on Portal Hypertension in Patients With CirrhosisHepatology, 1982
- The Effect of Propranolol on Portal Hypertension in Patients With Cirrhosis: A Hemodynamic StudyHepatology, 1982
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981
- PROPRANOLOL—A MEDICAL TREATMENT FOR PORTAL HYPERTENSION?The Lancet, 1980